Study supports Pfizer high-dose Lipitor strategy
New data that support using higher doses of Lipitor may provide another plank in Pfizers strategy to drive sales during its best-selling drugs sunsetting patent window.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.